Skip to content
drillr.ai
Sign up

YDESW

YD Bio Limited Warrants

NASDAQ · Healthcare · Biotechnology · TW

$0.35
−7.84%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—596.8K510.4K350.1K—
Cost of Revenue—639.0K355.0K196.7K—
Gross Profit—(42.1K)155.4K153.4K—
Operating Expenses
R&D Expense—1.6M491.4K——
SG&A Expense1.4M3.6M1.1M160.6K2.3M
General & Admin Expense——1.1M153.1K—
Selling & Marketing Expense——2.0K7.5K—
Other Expenses——(493.00)2.7K—
Total Operating Expenses1.4M5.2M1.6M163.3K2.3M
Cost and Expenses1.4M5.9M2.0M360.0K2.3M
Operating Income (EBIT)(1.4M)(5.3M)(1.5M)(9.8K)(2.3M)
Non-Operating
Interest Income326.8K80.2K11.8K290.00813.00
Interest Expense——772.002.1K—
Net Interest Income326.8K80.2K11.0K(1.9K)813.00
Other Non-Op Income/Expense(1.6M)(3.0M)75.5K27.5K6.1M
Non-Operating Income (excl Interest)1.6M3.0M(76.2K)(29.6K)(6.1M)
EBT (Pre-Tax Income)(3.0M)(8.3M)(1.4M)17.6K3.8M
Income Tax Expense(12.0K)(1.5K)25.1K4.1K2.1K
Bottom Line
Net Income(3.0M)(8.3M)(1.4M)13.6K3.8M
Earnings from Cont. Ops(3.0M)(8.3M)(1.4M)13.6K3.8M
Earnings from Discont. Ops—————
Bottom Line Net Income(3.0M)(8.3M)(1.4M)13.6K3.8M
Per Share
Basic EPS($0.99)($0.12)($0.56)$0.00$0.41
Diluted EPS($0.99)($0.12)($0.56)$0.00$0.41
Revenue Per Share$0.00$0.01$0.12$0.00$0.00
Shares
Basic Shares Outstanding3.4M66.7M4.1M70.1M9.3M
Diluted Shares Outstanding3.4M66.7M4.1M70.1M9.3M
Profitability Metrics
EBITDA(3.0M)(8.1M)(1.3M)22.2K3.8M
D&A—209.6K104.7K2.5K—
EBIT(3.0M)(8.3M)(1.4M)19.8K3.8M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025